FAPi-46 GA-68 Recruiting Phase 2 Trials for Pancreatic Ductal Adenocarcinoma (PDAC) / FAP Diagnostic

IndicationsStatusPurposePhase
RecruitingDiagnostic2
clinicaltrials.gov IdentifierTitleDrugs
NCT05262855
Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma